These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 19465161)
21. Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers. Zhai Y; Zhou G; Deng G; Xie W; Dong X; Zhang X; Yu L; Yang H; Yuan X; Zhang H; Zhi L; Yao Z; Shen Y; Qiang B; He F Gastroenterology; 2006 Jun; 130(7):2001-9. PubMed ID: 16762623 [TBL] [Abstract][Full Text] [Related]
22. [A study on the association of MTHFR C677T polymorphism with genetic susceptibility to hepatocellular carcinoma]. Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):196-8. PubMed ID: 16556414 [TBL] [Abstract][Full Text] [Related]
23. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287 [TBL] [Abstract][Full Text] [Related]
24. Genetic polymorphism in the manganese superoxide dismutase gene is associated with an increased risk for hepatocellular carcinoma in HCV-infected Moroccan patients. Ezzikouri S; El Feydi AE; Chafik A; Afifi R; El Kihal L; Benazzouz M; Hassar M; Pineau P; Benjelloun S Mutat Res; 2008 Jan; 649(1-2):1-6. PubMed ID: 18023606 [TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity. Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960 [TBL] [Abstract][Full Text] [Related]
26. PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence. Falleti E; Fabris C; Cmet S; Cussigh A; Bitetto D; Fontanini E; Fornasiere E; Bignulin S; Fumolo E; Bignulin E; Pirisi M; Toniutto P Liver Int; 2011 Sep; 31(8):1137-43. PubMed ID: 21745286 [TBL] [Abstract][Full Text] [Related]
27. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819 [TBL] [Abstract][Full Text] [Related]
28. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women. Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674 [TBL] [Abstract][Full Text] [Related]
29. Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Sonzogni L; Silvestri L; De Silvestri A; Gritti C; Foti L; Zavaglia C; Bottelli R; Mondelli MU; Civardi E; Silini EM Hepatology; 2002 Jul; 36(1):195-201. PubMed ID: 12085365 [TBL] [Abstract][Full Text] [Related]
30. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302 [TBL] [Abstract][Full Text] [Related]
31. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma]. Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046 [TBL] [Abstract][Full Text] [Related]
32. Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Wang Y; Kato N; Hoshida Y; Yoshida H; Taniguchi H; Goto T; Moriyama M; Otsuka M; Shiina S; Shiratori Y; Ito Y; Omata M Hepatology; 2003 Jan; 37(1):65-71. PubMed ID: 12500190 [TBL] [Abstract][Full Text] [Related]
33. Effects of E-cadherin (CDH1) gene promoter polymorphisms on the risk and clinicopathological development of hepatocellular carcinoma. Chien MH; Yeh KT; Li YC; Hsieh YH; Lin CH; Weng MS; Kuo WH; Yang SF J Surg Oncol; 2011 Sep; 104(3):299-304. PubMed ID: 21462191 [TBL] [Abstract][Full Text] [Related]
34. The association between the survivin -31G/C promoter polymorphism and hepatocellular carcinoma risk in a Turkish population. Bayram S; Akkız H; Bekar A; Akgöllü E Cancer Epidemiol; 2011 Dec; 35(6):555-9. PubMed ID: 21296634 [TBL] [Abstract][Full Text] [Related]
35. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135 [TBL] [Abstract][Full Text] [Related]
36. MTHFR C677T polymorphism and risk of HCC in patients with liver cirrhosis: role of male gender and alcohol consumption. Fabris C; Toniutto P; Falleti E; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Fumolo E; Avellini C; Minisini R; Pirisi M Alcohol Clin Exp Res; 2009 Jan; 33(1):102-7. PubMed ID: 18945219 [TBL] [Abstract][Full Text] [Related]
37. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma]. Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652 [TBL] [Abstract][Full Text] [Related]
38. Association study of microRNA polymorphisms with hepatocellular carcinoma in Korean population. Kim WH; Min KT; Jeon YJ; Kwon CI; Ko KH; Park PW; Hong SP; Rim KS; Kwon SW; Hwang SG; Kim NK Gene; 2012 Aug; 504(1):92-7. PubMed ID: 22583825 [TBL] [Abstract][Full Text] [Related]
39. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101 [TBL] [Abstract][Full Text] [Related]
40. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population]. Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]